FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment
A legfontosabb adatok
- Ki végzi
- Chinese University of Hong Kong
- Hol
- Hongkong1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 56 fő vett részt
- Kezdés
- 2017. ápr. 12.
- Befejezés
- 2023. dec. 16.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Fecal Microbiota Transplantation
- Sham
- Fecal and Mucosal Microbiota Assessment
- A regiszteradat frissítve
- 2024. augusztus 22.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 20 feltétel megnézéseKevesebb
Ki vehet részt
- Patients are aged 18 or above
- Patients have a diagnosis of IBS consistent with the Rome III criteria (13)
- Patients did not have adequate relief of global IBS symptoms and of IBS-related bloating at both the time of screening and the time of randomization
- Patients had undergone clinical investigations with colonoscopy within five years of recruitment
- Patients with written informed consent form provided
Ki nem vehet részt
- Patients have previous abdominal surgery (other than cholecystectomy or appendectomy)
- Patients have used antibiotic therapy or anti-inflammatory drugs within the past 7 days
- Patients have a history of inflammatory bowel disease or gastrointestinal malignancy
- Patients have human immunodeficiency virus infection
- Patients have a history of psychiatric illness (mania and schizophrenia)
- Patients have anxiety defined by having a Generalized Anxiety Disorder 7 (GAD7) score > 10
- Patients have active infection at the time of inclusion
- Patients have renal disease manifested by 1.5 times the ULN of serum creatinine or blood urea nitrogen level
- Patients have hepatic disease manifested by twice the upper limit of normal (ULN) for any of the following liver function tests: alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, or total bilirubin (except in isolated elevation of unconjugated bilirubin
- Patients have diabetes mellitus manifested by HbA1C > 6.5%
- Patients have abnormal thyroid function manifested by values of serum Sensitive Thyroid Stimulating Hormone and serum free T4 fall outside the reference range which is not controlled by thyroid medications
- Patients have constipation predominant IBS (according to the definition of Rome III criteria)
- Patients have depression defined by having a Patient Health Questionnaire-9 (PHQ-9) score > 15
- Patients have any other organic causes that can explain the symptoms of IBS
- Current pregnancy
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Irritable bowel syndrome (IBS) is a common functional bowel disorder of the gastrointestinal tract affecting up to 20 percent of the adolescent and adult populations. It is characterised by abdominal pain, irregular bowel habits, altered stool consistencies and bloating, and is associated with impaired quality of life. IBS can be categorised into diarrhoea predominant type (IBS-D), constipation predominant type (IBS-C), and mixed type (IBS-M). Fecal microbiota transplantation (FMT) defined as infusion of feces from healthy donors to affected subjects has shown impressive results with high cure rates in patients with recurrent clostridium difficile infections. The investigators propose a randomised, placebo-controlled trial of FMT in patients with IBS.
A vizsgálat 2 csoportja
- Fecal Microbiota TransplantationA vizsgált kezelés
FMT infusion and Fecal and Mucosal Microbiota Assessment
Kezelés: Fecal Microbiota Transplantation és Fecal and Mucosal Microbiota Assessment
- Sham infusionSzínlelt kezelés, összehasonlításként
Infusion with sham and Fecal and Mucosal Microbiota Assessment
Kezelés: Sham és Fecal and Mucosal Microbiota Assessment
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Randomised, Placebo-controlled Study on Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome With Fecal and Mucosal Microbiota Assessment
- Publikációk
- Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea.Alimentary pharmacology & therapeutics, 2023
- A regiszteradat frissítve
- 2024. augusztus 22.